173 related articles for article (PubMed ID: 30205412)
1. Epidemiological and Clinical Patterns of Kaposi Sarcoma: A 16-Year Retrospective Cross-Sectional Study from Yaoundé, Cameroon.
Tounouga DN; Kouotou EA; Nansseu JR; Zoung-Kanyi Bissek AC
Dermatology; 2018; 234(5-6):198-204. PubMed ID: 30205412
[TBL] [Abstract][Full Text] [Related]
2. Kaposi sarcoma: no longer an AIDS-defining illness? A retrospective study of Kaposi sarcoma cases with CD4 counts above 300/mm³ at presentation.
Daly ML; Fogo A; McDonald C; Morris-Jones R
Clin Exp Dermatol; 2014 Jan; 39(1):7-12. PubMed ID: 23691969
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and associated risk factors for Kaposi's sarcoma among HIV-positive patients in a referral hospital in Northern Tanzania: a retrospective hospital-based study.
Semango GP; Charles RM; Swai CI; Mremi A; Amsi P; Sonda T; Shao ER; Mavura DR; Joosten LAB; Sauli E; Nyindo M
BMC Cancer; 2018 Dec; 18(1):1258. PubMed ID: 30558571
[TBL] [Abstract][Full Text] [Related]
4. Kaposi sarcoma in Southern Finland (2006-2018).
Kluger N; Blomqvist C; Kivelä P
Int J Dermatol; 2019 Nov; 58(11):1258-1263. PubMed ID: 31222805
[TBL] [Abstract][Full Text] [Related]
5. Patterns of skin manifestations and their relationships with CD4 counts among HIV/AIDS patients in Cameroon.
Josephine M; Issac E; George A; Ngole M; Albert SE
Int J Dermatol; 2006 Mar; 45(3):280-4. PubMed ID: 16533229
[TBL] [Abstract][Full Text] [Related]
6. Evolution of Kaposi sarcoma in the past 30 years in a tertiary hospital of the European Mediterranean basin.
Marcoval J; Bonfill-Ortí M; Martínez-Molina L; Valentí-Medina F; Penín RM; Servitje O
Clin Exp Dermatol; 2019 Jan; 44(1):32-39. PubMed ID: 29934954
[TBL] [Abstract][Full Text] [Related]
7. [Seroprevalence of human herpes virus-8 in HIV-positive patients at the General Hospital of Yaounde - Cameroon].
Jacky NB; Paul N; Lilian M; Sylvie AD
Pan Afr Med J; 2015; 20():69. PubMed ID: 26090027
[TBL] [Abstract][Full Text] [Related]
8. Kaposi sarcoma in people living with HIV: incidence and associated factors in a French cohort between 2010 and 2015.
Poizot-Martin I; Lions C; Cheret A; Rey D; Duvivier C; Jacomet C; Allavena C; Huleux T; Bani-Sadr F; Obry-Roguet V; Makinson A;
AIDS; 2020 Mar; 34(4):569-577. PubMed ID: 31764070
[TBL] [Abstract][Full Text] [Related]
9. CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.
Caby F; Guiguet M; Weiss L; Winston A; Miro JM; Konopnicki D; Le Moing V; Bonnet F; Reiss P; Mussini C; Poizot-Martin I; Taylor N; Skoutelis A; Meyer L; Goujard C; Bartmeyer B; Boesecke C; Antinori A; Quiros-Roldan E; Wittkop L; Frederiksen C; Castagna A; Thurnheer MC; Svedhem V; Jose S; Costagliola D; Mary-Krause M; Grabar S;
Clin Infect Dis; 2021 Jul; 73(1):50-59. PubMed ID: 34370842
[TBL] [Abstract][Full Text] [Related]
10. Mucocutaneous manifestations in human immunodeficiency virus (HIV)-infected patients in Nouakchott, Mauritania.
Boushab BM; Malick Fall FZ; Ould Cheikh Mohamed Vadel TK; Ould Cheikh Melaïnine ML; Maazouz MV; Savadogo M; Basco LK
Int J Dermatol; 2017 Dec; 56(12):1421-1424. PubMed ID: 28960268
[TBL] [Abstract][Full Text] [Related]
11. A prospective ascertainment of cancer incidence in sub-Saharan Africa: The case of Kaposi sarcoma.
Semeere A; Wenger M; Busakhala N; Buziba N; Bwana M; Muyindike W; Amerson E; Maurer T; McCalmont T; LeBoit P; Musick B; Yiannoutsos C; Lukande R; Castelnuovo B; Laker-Oketta M; Kambugu A; Glidden D; Wools-Kaloustian K; Martin J
Cancer Med; 2016 May; 5(5):914-28. PubMed ID: 26823008
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's sarcoma in a hospital setting in Lomé (Togo): a study of 93 cases.
Pitche PT; Kombate K; Owono F; Tchangai-Walla K
Int J Dermatol; 2007 Oct; 46 Suppl 1():42-4. PubMed ID: 17919207
[TBL] [Abstract][Full Text] [Related]
13. Differences in androgens of HIV positive patients with and without Kaposi sarcoma.
Christeff N; Winter C; Gharakhanian S; Thobie N; Wirbel E; Costagliola D; Nunez EA; Rozenbaum W
J Clin Pathol; 1995 Jun; 48(6):513-8. PubMed ID: 7665693
[TBL] [Abstract][Full Text] [Related]
14. Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.
Phipps W; Ssewankambo F; Nguyen H; Saracino M; Wald A; Corey L; Orem J; Kambugu A; Casper C
PLoS One; 2010 Nov; 5(11):e13936. PubMed ID: 21103057
[TBL] [Abstract][Full Text] [Related]
15. Influence of HIV infection on presentation of Kaposi's sarcoma.
Ahmed A; Isa MS; Garba HA; Kalayi GD; Muhammad I; Egler LJ
Trop Doct; 2001 Jan; 31(1):42-5. PubMed ID: 11205606
[TBL] [Abstract][Full Text] [Related]
16. Navigating the heterogeneous landscape of pediatric Kaposi sarcoma.
Kamiyango W; Villiera J; Silverstein A; Peckham-Gregory E; Campbell LR; El-Mallawany NK
Cancer Metastasis Rev; 2019 Dec; 38(4):749-758. PubMed ID: 31845111
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma in Nigeria.
Onunu AN; Okoduwa C; Eze EU; Adeyekun AA; Kubeyinje EP; Schwartz RA
Int J Dermatol; 2007 Mar; 46(3):264-7. PubMed ID: 17343581
[TBL] [Abstract][Full Text] [Related]
18. One hundred and five Kaposi sarcoma patients: a clinical study in Xinjiang, Northwest of China.
Wu XJ; Pu XM; Kang XJ; Halifu Y; An CX; Zhang DZ; Yakeya B; Mijit J
J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1545-52. PubMed ID: 25350316
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of Kaposi's sarcoma in patients with acquired immunodeficiency syndrome in São Paulo, Brazil.
Yoshioka MC; Alchorne MM; Porro AM; Tomimori-Yamashita J
Int J Dermatol; 2004 Sep; 43(9):643-7. PubMed ID: 15357742
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study.
AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord
Clin Infect Dis; 2017 Oct; 65(8):1316-1326. PubMed ID: 28531260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
